CPAMS in Nova Scotia, Canada
  • Currently over 800 Nova Scotia patients are using the service.
  • 946 patients were studied in a one year pilot project funded by the Nova Scotia Ministry of Health and administered by the Pharmacy Association of Nova Scotia (PANS).
  •  Over 41 Nova Scotia pharmacies provide the service.
Anticoagulant control
  • Control is measured by assessing the time within the therapeutic range (TTR). A TTR greater than 60% is regarded as “good” control.
  • The TTR for the whole CPAMS population was 71.4% and 75.7% for the most recent five months of the study.
  • Patients achieved good control (TTR>60%).  72.5% of patients had a TTR>65%.
  • The risk of bleeding is associated with a high INR result.
  • Only 0.6% of INR results were greater than 5
  • Only 0.1% of INR results were greater than 8.0
  • CPAMS provides an efficient safe anticoagulant monitoring service giving a consistent high level of anticoagulant control.

See full PANS CPAMS Report